ETF Foundry
DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.
accruals factor · long-only model fund

Foundry Earnings Quality (Accruals) Factor ETF

ETF Foundry Research (hypothetical) · rebalanced monthly

FACCHYPOTHETICAL MODEL
Since ’99
−74%
Expense Ratio
0.29%
placeholder
Holdings
223
cap-weighted
Inception
Mar 2021
placeholder
Full Sharpe
-0.23
Ann. Return (LS)
-3.6%
Ann. Volatility
16.0%
Max Drawdown
-73.5%
Test Sharpe ’19–26
-0.24
Test FF5 α (ann.)
-3.3%
vs Fama-French 5
Test FF5 α t-stat
-0.47
not significant
Monthly turnover
19%
of the long leg, per rebalance
Cumulative return (LS)
-74%
over 331 months
This fund holds the long leg only
Long leg Sharpe
0.45
what this fund holds
Long leg ann. return
10.2%
buyable, long-only
Long-short Sharpe
-0.23
requires shorting
Bottom bucket ann. return
13.8%
the basket shorted

Every other metric on this page is the long-shortstrategy, which needs a short book. This fund is the long leg alone, so these are the figures for what it actually holds. The bottom-bucket number is that basket’s own return — not short P&L.

Hypothetical growth of $1 — long-short backtest

Gross of the placeholder expense ratio and trading costs · not investor results

331 months

Holdings

Every constituent of the long leg — sort, search or filter by sector

223 of 223 · 100.0% of book
TickerCompanySectorMarket capWeight
1NFLX
NETFLIX INCCommunication Services$290.47B
23.36%
2SNOW
SNOWFLAKE INCTechnology$93.20B
7.49%
3TTWO
TAKE TWO INTERACTIVE SOFTWARE INCCommunication Services$43.94B
3.53%
4CRWV
COREWEAVE INCTechnology$39.94B
3.21%
5RVMD
REVOLUTION MEDICINES INCHealthcare$39.58B
3.18%
6WDAY
WORKDAY INCTechnology$35.76B
2.88%
7DXCM
DEXCOM INCHealthcare$29.58B
2.38%
8ECHO
ECHO GLOBAL LOGISTICS INCIndustrials$26.66B
2.14%
9CPRT
COPART INCIndustrials$25.56B
2.06%
10VRSN
VERISIGN INCTechnology$25.27B
2.03%
11MDB
MONGODB INCTechnology$25.12B
2.02%
12MRNA
MODERNA INCHealthcare$24.53B
1.97%
13CPAY
CORPAY INCTechnology$23.91B
1.92%
14UTHR
UNITED THERAPEUTICS CORPHealthcare$22.74B
1.83%
15RIVN
RIVIAN AUTOMOTIVE INCConsumer Cyclical$22.00B
1.77%
16IFF
INTERNATIONAL FLAVORS & FRAGRANCES INCBasic Materials$19.96B
1.61%
17CRCL
CIRCLE INTERNET GROUP INCFinancial Services$15.03B
1.21%
18ONTO
ONTO INNOVATION INCTechnology$13.92B
1.12%
19BTSG
BRIGHTSPRING HEALTH SERVICES INCHealthcare$13.71B
1.10%
20APA
APA CORPEnergy$12.45B
1.00%
21BMRN
BIOMARIN PHARMACEUTICAL INCHealthcare$11.52B
0.93%
22HUBS
HUBSPOT INCTechnology$11.49B
0.92%
23CYTK
CYTOKINETICS INCHealthcare$9.98B
0.80%
24HALO
HALOZYME THERAPEUTICS INCHealthcare$9.23B
0.74%
25WULF
TERAWULF INCFinancial Services$9.00B
0.72%
26OSCR
OSCAR HEALTH INCHealthcare$8.77B
0.71%
27ZG
ZILLOW GROUP INCCommunication Services$7.71B
0.62%
28SM
SM ENERGY COEnergy$7.51B
0.60%
29MIRM
MIRUM PHARMACEUTICALS INCHealthcare$7.25B
0.58%
30CIFR
CIPHER DIGITAL INCFinancial Services$7.18B
0.58%
31HNGE
HINGE HEALTH INCHealthcare$6.74B
0.54%
32IDCC
INTERDIGITAL INCCommunication Services$6.73B
0.54%
33CORZ
CORE SCIENTIFIC INCTechnology$6.66B
0.54%
34BYD
BOYD GAMING CORPConsumer Cyclical$6.52B
0.52%
35LUMN
LUMEN TECHNOLOGIES INCCommunication Services$6.47B
0.52%
36SRRK
SCHOLAR ROCK HOLDING CORPHealthcare$6.33B
0.51%
37LYFT
LYFT INCTechnology$5.89B
0.47%
38ENPH
ENPHASE ENERGY INCTechnology$5.48B
0.44%
39HRB
H&R BLOCK INCConsumer Cyclical$5.33B
0.43%
40TVTX
TRAVERE THERAPEUTICS INCHealthcare$5.27B
0.42%
41LAUR
LAUREATE EDUCATION INCConsumer Defensive$5.10B
0.41%
42MGY
MAGNOLIA OIL & GAS CORPEnergy$5.04B
0.41%
43DFTX
DEFINIUM THERAPEUTICS INCHealthcare$4.83B
0.39%
44CRC
CALIFORNIA RESOURCES CORPEnergy$4.69B
0.38%
45LBRDA
LIBERTY BROADBAND CORPCommunication Services$4.43B
0.36%
46VKTX
VIKING THERAPEUTICS INCHealthcare$4.31B
0.35%
47ALHC
ALIGNMENT HEALTHCARE INCHealthcare$4.26B
0.34%
48PI
IMPINJ INCTechnology$4.21B
0.34%
49CNR
CORE NATURAL RESOURCES INCBasic Materials$4.18B
0.34%
50MARA
MARA HOLDINGS INCFinancial Services$4.08B
0.33%
51LION
LIONSGATE STUDIOS CORPCommunication Services$4.03B
0.32%
52DOCS
DOXIMITY INCHealthcare$3.94B
0.32%
53POWI
POWER INTEGRATIONS INCTechnology$3.93B
0.32%
54TDS
TELEPHONE & DATA SYSTEMS INCCommunication Services$3.90B
0.31%
55DK
DELEK US HOLDINGS INCEnergy$3.88B
0.31%
56RLAY
RELAY THERAPEUTICS INCHealthcare$3.81B
0.31%
57PTEN
PATTERSON UTI ENERGY INCEnergy$3.80B
0.31%
58DNLI
DENALI THERAPEUTICS INCHealthcare$3.70B
0.30%
59MSGE
MADISON SQUARE GARDEN ENTERTAINMENT CORPConsumer Cyclical$3.56B
0.29%
60CRGY
CRESCENT ENERGY COEnergy$3.55B
0.29%
61RNG
RINGCENTRAL INCTechnology$3.46B
0.28%
62RCUS
ARCUS BIOSCIENCES INCHealthcare$3.44B
0.28%
63CLSK
CLEANSPARK INCFinancial Services$3.34B
0.27%
64SEDG
SOLAREDGE TECHNOLOGIES INCTechnology$3.25B
0.26%
65AD
ARRAY DIGITAL INFRASTRUCTURE INCCommunication Services$3.02B
0.24%
66FRSH
FRESHWORKS INCTechnology$3.01B
0.24%
67BRZE
BRAZE INCTechnology$2.98B
0.24%
68RARE
ULTRAGENYX PHARMACEUTICAL INCHealthcare$2.88B
0.23%
69LCID
LUCID GROUP INCConsumer Cyclical$2.87B
0.23%
70SUPN
SUPERNUS PHARMACEUTICALS INCHealthcare$2.79B
0.22%
71CLDX
CELLDEX THERAPEUTICS INCHealthcare$2.77B
0.22%
72VERA
VERA THERAPEUTICS INCHealthcare$2.76B
0.22%
73VISN
VISTANCE NETWORKS INCTechnology$2.74B
0.22%
74NVTS
NAVITAS SEMICONDUCTOR CORPTechnology$2.68B
0.22%
75KOD
KODIAK SCIENCES INCHealthcare$2.67B
0.21%
76PGNY
PROGYNY INCHealthcare$2.50B
0.20%
77TALO
TALOS ENERGY INCEnergy$2.49B
0.20%
78BCRX
BIOCRYST PHARMACEUTICALS INCHealthcare$2.36B
0.19%
79AGIO
AGIOS PHARMACEUTICALS INCHealthcare$2.36B
0.19%
80BHVN
BIOHAVEN LTDHealthcare$2.32B
0.19%
81NOG
NORTHERN OIL & GAS INCEnergy$2.24B
0.18%
82IOVA
IOVANCE BIOTHERAPEUTICS INCHealthcare$2.23B
0.18%
83SION
SIONNA THERAPEUTICS INCHealthcare$2.23B
0.18%
84AGL
AGILON HEALTH INCHealthcare$2.17B
0.17%
85VERX
VERTEX INCTechnology$2.07B
0.17%
86CDNA
CAREDX INCHealthcare$2.05B
0.17%
87SNDX
SYNDAX PHARMACEUTICALS INCHealthcare$2.02B
0.16%
88AMLX
AMYLYX PHARMACEUTICALS INCHealthcare$1.97B
0.16%
89CPRI
CAPRI HOLDINGS LTDConsumer Cyclical$1.89B
0.15%
90SAM
BOSTON BEER CO INCConsumer Defensive$1.86B
0.15%
91MQ
MARQETA INCTechnology$1.85B
0.15%
92NVCR
NOVOCURE LTDHealthcare$1.84B
0.15%
93LIND
LINDBLAD EXPEDITIONS HOLDINGS INCIndustrials$1.81B
0.15%
94ASAN
ASANA INCTechnology$1.77B
0.14%
95ZYME
ZYMEWORKS INCHealthcare$1.77B
0.14%
96TDOC
TELADOC HEALTH INCHealthcare$1.70B
0.14%
97ANAB
ANAPTYSBIO INCHealthcare$1.69B
0.14%
98FTRE
FORTREA HOLDINGS INCHealthcare$1.68B
0.14%
99CMPS
COMPASS PATHWAYS PLCHealthcare$1.67B
0.13%
100TH
TARGET HOSPITALITY CORPIndustrials$1.64B
0.13%
101TE
T1 ENERGY INCIndustrials$1.63B
0.13%
102PUMP
PROPETRO HOLDING CORPEnergy$1.59B
0.13%
103VIR
VIR BIOTECHNOLOGY INCHealthcare$1.59B
0.13%
104NTLA
INTELLIA THERAPEUTICS INCHealthcare$1.59B
0.13%
105BRUN
BOOST RUN INCTechnology$1.50B
0.12%
106AHCO
ADAPTHEALTH CORPHealthcare$1.49B
0.12%
107TRS
TRIMAS CORPConsumer Cyclical$1.46B
0.12%
108MLTX
MOONLAKE IMMUNOTHERAPEUTICSHealthcare$1.45B
0.12%
109ARLO
ARLO TECHNOLOGIES INCBasic Materials$1.45B
0.12%
110YELP
YELP INCCommunication Services$1.44B
0.12%
111AIP
ARTERIS INCTechnology$1.43B
0.12%
112BJRI
BJS RESTAURANTS INCConsumer Cyclical$1.42B
0.11%
113CXM
SPRINKLR INCTechnology$1.37B
0.11%
114AMN
AMN HEALTHCARE SERVICES INCHealthcare$1.36B
0.11%
115REAL
THEREALREAL INCConsumer Cyclical$1.35B
0.11%
116BW
BABCOCK & WILCOX ENTERPRISES INCIndustrials$1.35B
0.11%
117DMLP
DORCHESTER MINERALS LPEnergy$1.31B
0.11%
118FCEL
FUELCELL ENERGY INCIndustrials$1.25B
0.10%
119NBR
NABORS INDUSTRIES LTDEnergy$1.24B
0.10%
120HTLD
HEARTLAND EXPRESS INCIndustrials$1.19B
0.10%
121MMI
MARCUS & MILLICHAP INCReal Estate$1.18B
0.09%
122MGTX
MEIRAGTX HOLDINGS PLCHealthcare$1.15B
0.09%
123EYPT
EYEPOINT INCHealthcare$1.12B
0.09%
124EVLV
EVOLV TECHNOLOGIES HOLDINGS INCIndustrials$1.02B
0.08%
125PCRX
PACIRA BIOSCIENCES INCHealthcare$1.01B
0.08%
126FBRX
FORTE BIOSCIENCES INCHealthcare$1.00B
0.08%
127EVC
ENTRAVISION COMMUNICATIONS CORPCommunication Services$984M
0.08%
128KURA
KURA ONCOLOGY INCHealthcare$964M
0.08%
129ANNX
ANNEXON INCHealthcare$950M
0.08%
130HPK
HIGHPEAK ENERGY INCEnergy$931M
0.07%
131GLIBA
GCI LIBERTY INCCommunication Services$881M
0.07%
132REPL
REPLIMUNE GROUP INCHealthcare$859M
0.07%
133SG
SWEETGREEN INCConsumer Cyclical$841M
0.07%
134CYRX
CRYOPORT INCIndustrials$832M
0.07%
135CODI
COMPASS DIVERSIFIED HOLDINGSIndustrials$777M
0.06%
136BBNX
BETA BIONICS INCHealthcare$771M
0.06%
137REPX
RILEY EXPLORATION PERMIAN INCEnergy$759M
0.06%
138IBTA
IBOTTA INCTechnology$734M
0.06%
139AURA
AURA BIOSCIENCES INCHealthcare$723M
0.06%
140TXO
TXO PARTNERS LPEnergy$707M
0.06%
141SPRY
ARS PHARMACEUTICALS INCHealthcare$695M
0.06%
142PKE
PARK AEROSPACE CORPIndustrials$677M
0.05%
143SWBI
SMITH & WESSON BRANDS INCIndustrials$665M
0.05%
144VTS
VITESSE ENERGY INCEnergy$664M
0.05%
145CNNE
CANNAE HOLDINGS INCConsumer Cyclical$657M
0.05%
146ACHV
ACHIEVE LIFE SCIENCES INCHealthcare$644M
0.05%
147PUBM
PUBMATIC INCTechnology$591M
0.05%
148NGNE
NEUROGENE INCHealthcare$590M
0.05%
149ETD
ETHAN ALLEN INTERIORS INCConsumer Cyclical$580M
0.05%
150WEAV
WEAVE COMMUNICATIONS INCHealthcare$575M
0.05%
151MLR
MILLER INDUSTRIES INCConsumer Cyclical$566M
0.05%
152EGY
VAALCO ENERGY INCEnergy$553M
0.04%
153WNC
WABASH NATIONAL CORPIndustrials$547M
0.04%
154CTRN
CITI TRENDS INCConsumer Cyclical$535M
0.04%
155ARVN
ARVINAS INCHealthcare$517M
0.04%
156SPIR
SPIRE GLOBAL INCIndustrials$488M
0.04%
157PAYS
PAYSIGN INCTechnology$478M
0.04%
158VMD
VIEMED HEALTHCARE INCHealthcare$466M
0.04%
159AMCX
AMC GLOBAL MEDIA INCCommunication Services$461M
0.04%
160STRZ
STARZ ENTERTAINMENT CORPCommunication Services$450M
0.04%
161SRTA
STRATA CRITICAL MEDICAL INCIndustrials$446M
0.04%
162BNED
BARNES & NOBLE EDUCATION INCConsumer Cyclical$437M
0.04%
163ASPN
ASPEN AEROGELS INCBasic Materials$425M
0.03%
164MCFT
MASTERCRAFT BOAT HOLDINGS INCConsumer Cyclical$407M
0.03%
165ENTA
ENANTA PHARMACEUTICALS INCHealthcare$400M
0.03%
166EBS
EMERGENT BIOSOLUTIONS INCHealthcare$394M
0.03%
167UPB
UPSTREAM BIO INCHealthcare$382M
0.03%
168ZNTL
ZENTALIS PHARMACEUTICALS INCHealthcare$364M
0.03%
169MTRX
MATRIX SERVICE COIndustrials$342M
0.03%
170RTAC
RENATUS TACTICAL ACQUISITION CORP IIndustrials$329M
0.03%
171VNDA
VANDA PHARMACEUTICALS INCHealthcare$327M
0.03%
172FNKO
FUNKO INCConsumer Cyclical$326M
0.03%
173PAMT
PAMT CORPIndustrials$311M
0.02%
174FHTX
FOGHORN THERAPEUTICS INCHealthcare$305M
0.02%
175ALCO
ALICO INCConsumer Defensive$304M
0.02%
176PNRG
PRIMEENERGY RESOURCES CORPEnergy$302M
0.02%
177TKNO
ALPHA TEKNOVA INCHealthcare$291M
0.02%
178UCFI
CN HEALTHY FOOD TECH GROUP CORPConsumer Defensive$288M
0.02%
179TRDA
ENTRADA THERAPEUTICS INCHealthcare$268M
0.02%
180ALMU
AELUMA INCTechnology$267M
0.02%
181LOVE
LOVESAC COConsumer Cyclical$267M
0.02%
182SVCO
SILVACO GROUP INCTechnology$260M
0.02%
183VNME
VENDOME ACQUISITION CORP IIndustrials$254M
0.02%
184ARTV
ARTIVA BIOTHERAPEUTICS INCHealthcare$241M
0.02%
185GLSI
GREENWICH LIFESCIENCES INCHealthcare$240M
0.02%
186QUIK
QUICKLOGIC CORPTechnology$237M
0.02%
187GTE
GRAN TIERRA ENERGY INCEnergy$233M
0.02%
188KPTI
KARYOPHARM THERAPEUTICS INCHealthcare$216M
0.02%
189ALTG
ALTA EQUIPMENT GROUP INCIndustrials$208M
0.02%
190PAL
PROFICIENT AUTO LOGISTICS INCIndustrials$197M
0.02%
191SRI
STONERIDGE INCConsumer Cyclical$197M
0.02%
192COOK
TRAEGER INCConsumer Cyclical$193M
0.02%
193EAF
GRAFTECH INTERNATIONAL LTDIndustrials$181M
0.01%
194INFU
INFUSYSTEM HOLDINGS INCHealthcare$180M
0.01%
195KVHI
KVH INDUSTRIES INCTechnology$178M
0.01%
196INSE
INSPIRED ENTERTAINMENT INCConsumer Cyclical$174M
0.01%
197KORE
KORE GROUP HOLDINGS INCCommunication Services$163M
0.01%
198PED
PEDEVCO CORPEnergy$161M
0.01%
199RCEL
AVITA MEDICAL INCHealthcare$157M
0.01%
200HOFT
HOOKER FURNISHINGS CORPConsumer Cyclical$152M
0.01%
201CHPT
CHARGEPOINT HOLDINGS INCConsumer Cyclical$146M
0.01%
202ACNT
ASCENT INDUSTRIES COBasic Materials$138M
0.01%
203DMRC
DIGIMARC CORPTechnology$133M
0.01%
204AARD
AARDVARK THERAPEUTICS INCHealthcare$128M
0.01%
205VATE
INNOVATE CORPIndustrials$123M
0.01%
206INSG
INSEEGO CORPTechnology$122M
0.01%
207UFI
UNIFI INCConsumer Cyclical$118M
0.01%
208TCX
TUCOWS INCTechnology$114M
0.01%
209SSTI
SOUNDTHINKING INCTechnology$111M
0.01%
210TRT
TRIO-TECH INTERNATIONALTechnology$103M
0.01%
211CHRN
CHRONOSCALE CORPIndustrials$94M
0.01%
212GEOS
GEOSPACE TECHNOLOGIES CORPEnergy$88M
0.01%
213RLYB
RALLYBIO CORPHealthcare$87M
0.01%
214AEYE
AUDIOEYE INCTechnology$82M
0.01%
215PIII
P3 HEALTH PARTNERS INCHealthcare$78M
0.01%
216ACET
ADICET BIO INCHealthcare$76M
0.01%
217SCLX
SCILEX HOLDING COHealthcare$72M
0.01%
218BGSF
BGSF INCIndustrials$65M
0.01%
219BRID
BRIDGFORD FOODS CORPConsumer Defensive$59M
0.00%
220SKIL
SKILLSOFT CORPConsumer Defensive$58M
0.00%
221LNZA
LANZATECH GLOBAL INCIndustrials$56M
0.00%
222STEM
STEM INCTechnology$56M
0.00%
223EXOZ
EXOZYMES INCHealthcare$51M
0.00%

Full long-leg book as of July 2026 · cap-weighted · total market cap $1.24T. Hypothetical model holdings — not a registered fund’s portfolio.

Sector Breakdown

10 sectors
Communication Services
30.2%
Technology
26.2%
Healthcare
23.6%
Industrials
5.5%
Energy
4.4%
Consumer Cyclical
4.2%
Financial Services
3.1%
Basic Materials
2.1%
Consumer Defensive
0.6%
Real Estate
0.1%

Portfolio Style

Size × value map of the long-leg book

223 classified
Value
Blend
Growth
Large
Mid
Small
2%3
39%13
22%15
3%18
6%30
6%30
1%32
1%20
1%18

Share of long-leg capital by market cap × book-to-market, using terciles of the 3,283-name universe at July 2026. Rows: Large ≥ $5.2B, Small < $819M. Columns: Value ≥ 0.62, Growth < 0.34 B/M. The dot marks the capital-weighted centroid of the book — 88% toward Large, 64% toward Growth. +20% unclassified (44 missing size/value). Hypothetical holdings — descriptive, not realized P&L.

Tilt over time
Size tilt88% → Large
SmallLarge
Value ↔ growth tilt64% → Growth
ValueGrowth

Capital-weighted centroid of the long leg, December 1998July 2026; the right-hand end is the same value as the box’s dot. 223 names now. Hypothetical holdings — descriptive, not P&L.

Constraint checks

How this book measures against the concentration and liquidity rules — as implemented here

How this book was built

These are UNCONSTRAINED factor sleeves: the construction pipeline sorts on a signal and cap-weights the top bucket, applying no issuer cap, no industry cap and no liquidity screen beyond the universe filter. A failing test therefore reports a constraint that was never applied during construction — it is not a defect in the strategy and not an error in the data. The same signal can be solved subject to these constraints.

Passed
3
Failed
2
Not tested
2
Independent checks
7

7 independent checks plus 1 arithmetically implied by another check (RIC / IRC 851(b)(3)(A) 50% bucket), which is reported separately so the tally cannot overstate scrutiny.

2 of 7 checks could not be tested. Those are neither passes nor failures — they are gaps in what the data can answer, and they are excluded from the passed count above rather than folded into it.

  • The fund will not concentrate: no more than 25% of total assets in any one industry (excluding government securities and cash items).

    Required
    <= 25.0%
    Actual
    28.7%
    Margin
    -3.7%
  • Days required to liquidate the largest position at 20% of one day's dollar volume.

    Required
    <= 7.0 days
    Actual
    unbounded
    Margin
Reported separately — arithmetically implied

Engineering approximation of the cited rules for a DRAFT / HYPOTHETICAL model portfolio that is not a registered fund. This reports whether the portfolio passes the stated test AS IMPLEMENTED HERE; it is not a compliance opinion and is not a statement that any fund is compliant. Real filings need securities counsel.

No verdict sits within 1.0pp of its limit.

Data version — panel=20260719T025334 rows=2239262 asof=202607 issuers=20260719T014536 rates=20260804T224700

Measured on the 2026-07 formation date across 223 holdings (cap-weighted). A different formation date can produce different verdicts.

Derivatives risk (Rule 18f-4)

Whether this long-only book is subject to the VaR tests at all

This assessment describes the long-only book this fund holds — the top bucket only.

Governing rule
Rule 18f-4(c)(4) limited derivatives user exception

This fund QUALIFIES for the limited-derivatives-user exception, so it is excepted from the VaR tests; the ratio below is informational, not the operative limit.

Limited derivatives user exceptionby construction

Rule 18f-4(c)(4): a fund whose derivatives exposure (gross notional, including the value of assets sold short) is <= 10% of net assets is excepted from the VaR tests and the full derivatives risk management program.

Qualifies
Required
<= 10% of net assets
Exposure
0% of net assets
Margin
+10pp

No confidence interval: this follows from portfolio construction, not from an estimate.

Rule 18f-4(c)(2)(i): fund VaR at 99% over 20 trading days must not exceed 200% of the designated reference portfolio's VaR on the same basis.

Informational — does not govern

This fund is excepted from the VaR tests, so the ratio below is context rather than the operative limit. It is shown because it is still a description of the book’s risk, not because it decides anything.

Measured
1.9 (95% CI 1.1-2.3)
x reference VaR
Limit
2.00x
<= 2.00x reference VaR
Fund VaR
18.6%
99% / 20d
Reference
9.6%
FF5 market (mkt)

historical method · 331 monthly observations · about 3.3 in the 99% tail · paired percentile bootstrap over months

Same test, three estimators
historical
1.93x
within
parametric
1.45x
within
cornish fisher
1.55x
within

The estimators differ materially in value but agree on the verdict. Historical and Gaussian fund VaR differ by 33%; both still land on the same side of the 2x limit.

Engineering approximation of SEC Rule 18f-4 for research display. Not a compliance opinion and not a determination that any fund is compliant. Hypothetical model portfolio, not a registered fund.

The research long-short construction behind this factor does not qualify for this exception — a dollar-neutral book counts its full short notional, which is 100% of net assets against a 10% threshold. This product sidesteps that by holding the long leg alone, which is also why the long-leg Sharpe is reported separately throughout the site.

See the long-short verdict on the factor page →

Since publication

Did the edge survive the paper coming out?

published 1996
Entirely since publication
All 331 months of our record post-date the 1996 paper.
Sharpe -0.23-3.6% p.a.January 1999July 2026

There is no “before” to compare against — the predictor was already public when our data begins, so every month shown is out-of-sample relative to the original study.

Split at January of the year after the factor was published. The post-publication stretch IS genuinely out-of-sample relative to the original study -- the predictor was public by then -- so it speaks to whether the effect survived being known. Nothing is fitted here, so this is performance SINCE PUBLICATION, not validation of a model. Note the 'pre' side is our data before publication (our panel starts ~1999), NOT the study's original in-sample period, which usually ran decades earlier; a decay figure compares before-vs-after within our sample and is not a comparison against the published result.

Consistency across eras

Is this record broadly durable, or one regime?

26 windows
Positive windows
46%
12 of 26 3-year windows made money
Worst window
-1.51
Sharpe, January 2005 – December 2007
January 1999July 2026
Median Sharpe
-0.11
Dispersion
0.65
Best window
1.18

3-year rolling windows, stepping 1 year (26 windows). Dispersion is the spread of window Sharpes — higher means the record depends more on which era you look at.

Rules-based factors fit no parameters, so these windows are not out-of-sample tests and do not validate a fitted model. They show whether the factor's record is consistent across eras or driven by one regime.

Returns

Long leg is what this fund holds — long-short is shown for reference

since January 1999
Trailing
PeriodLong legLong-short
1 yearcum.-4.2%-19.8%
3 yearsp.a.15.7%-17.9%
5 yearsp.a.11.2%-3.4%
10 yearsp.a.15.0%-4.6%
Since inceptionp.a.7.9%-4.8%
Calendar years
YearLong legLong-short
20267 mo-1.1%-8.3%
20258.4%-25.5%
202431.4%-28.4%
202369.2%54.2%
2022-32.6%13.8%
202125.9%-0.2%
202026.2%-26.9%
201922.9%-2.0%
2018-1.9%5.1%
201725.2%-7.2%
201619.7%9.5%
201511.4%7.0%
20146.4%-8.4%
201344.6%-5.2%
201227.2%27.1%
2011-4.6%-4.0%
201022.7%10.6%
200958.2%-5.9%
2008-39.0%7.3%
20078.3%-21.2%
200612.3%-7.5%
20053.8%-10.4%
200413.9%5.8%
200363.3%31.7%
2002-49.0%-30.5%
2001-24.6%-17.3%
2000-37.0%-12.2%
199925.4%-32.5%

Long leg = the top bucket this fund holds; long-short additionally shorts the bottom bucket and is not achievable in a long-only vehicle. Trailing figures run through July 2026: 1 year is a plain cumulative 12-month return (cum.), 3 years and longer are annualised (p.a.). Years marked with a month count are partial. These match the fact sheet’s tables by construction. Hypothetical backtest, gross of the placeholder expense ratio and trading costs — not investor results.

Fund Facts

Ticker (pseudo)FACC
IssuerETF Foundry Research (hypothetical)
SeriesHypothetical Model Portfolio Series (not a registered trust)
Expense ratio0.29% (placeholder)
Inception2021-03-10 (placeholder)
Listing exchangeNot listed (hypothetical)
CUSIPNot applicable (hypothetical model portfolio)
RebalanceMonthly
Holdings as ofJuly 2026
Total mkt cap (long leg)$1.24T

Methodology

The Foundry Earnings Quality (Accruals) Factor ETF tracks a rules-based model that ranks liquid U.S. common stocks (price > $5, market-cap floor) each month by a Earnings Quality (Accruals) signal and holds the top decile with the lowest values. Signals are computed from point-in-time Sharadar fundamentals and total-return prices. The portfolio reconstitutes monthly and is cap-weighted within the long leg.

This is a hypothetical model portfolio for research display only — not a registered fund, not an offer, and not investment advice.

Documents (draft — hypothetical)

Auto-generated from the model’s metrics and current holdings. Every document is labeled DRAFT / hypothetical.

Summary Prospectus

Objective, fees, strategy, and key risks.

View →
Prospectus

Full strategy, model methodology, and risks.

View →
Statement of Additional Information

Policies, construction, and governance.

View →
Fact Sheet

One-page snapshot with top holdings.

View →
Daily Holdings

Full current constituent list.

View →

DRAFT — HYPOTHETICAL MODEL PORTFOLIO — NOT A REGISTERED FUND, NOT AN OFFER TO SELL SECURITIES, NOT INVESTMENT ADVICE.